The direct effects of single IDH AML-associated mutations on human HSPCs are poorly studied, so it remains unclear how they affect cell fate decisions, promote leukemogenesis, and contribute to the maintenance and progression of the malignant phenotype. Here, IDH2 is linked to acute myeloid leukemia.